Skip Nav Destination
Issues
November 2024
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
ISSN 0030-2414
EISSN 1423-0232
In this Issue
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2024, Vol. 102, No. 11
Clinical Study
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
Subject Area:
Oncology
Tiffany Ting-Fong Liu; Jason Chia-Hsien Cheng; Yu-Hsuan Chen; Feng-Ming Hsu; Keng-Hsueh Lan; Chao-Yuan Huang; Chun-Wei Wang; Sung-Hsin Kuo
Oncology (2024) 102 (11): 913–923.
https://doi.org/10.1159/000538321
Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection
Subject Area:
Oncology
Oncology (2024) 102 (11): 924–934.
https://doi.org/10.1159/000538456
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
Subject Area:
Oncology
Oncology (2024) 102 (11): 935–943.
https://doi.org/10.1159/000538455
Myocardial Infarction in Chronic Myeloid Leukemia: Results from the Nationwide Readmission Database
Subject Area:
Oncology
Elrazi A. Ali; Neel Patel; Mazin Khalid; Rasha Kaddoura; Madhumathi Kalavar; Jacob Shani; Mohamed Yassin
Oncology (2024) 102 (11): 944–951.
https://doi.org/10.1159/000539149
Serum Uric Acid Level May Be a Predictive Factor for BRAF V600E Mutation in Older Patients with Metastatic Colorectal Cancer: An Exploratory Analysis
Subject Area:
Oncology
Oncology (2024) 102 (11): 952–959.
https://doi.org/10.1159/000539981
SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma
Subject Area:
Oncology
Hiroki Morishita; Ryota Otsuka; Kentaro Murakami; Satoshi Endo; Takeshi Toyozumi; Yasunori Matsumoto; Tadashi Shiraishi; Shinichiro Iida; Tenshi Makiyama; Yuri Nishioka; Jie Hu; Abula Maiyulan; Hisahiro Matsubara
Oncology (2024) 102 (11): 960–968.
https://doi.org/10.1159/000540247
Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas
Subject Area:
Oncology
Oncology (2024) 102 (11): 969–978.
https://doi.org/10.1159/000540521
Research Article
Comprehensive Genomic Characterization in Ovarian Low-Grade and Chemosensitive and Chemoresistant High-Grade Serous Carcinomas
Subject Area:
Oncology
Oncology (2024) 102 (11): 979–987.
https://doi.org/10.1159/000538948
Paraneoplastic Hyperthyroidism in Advanced Testicular Non-Seminomatous Germ Cell Tumors: Prevalence and Clinical Management
Subject Area:
Oncology
Oncology (2024) 102 (11): 988–995.
https://doi.org/10.1159/000538634
Relationship between Anaplastic Lymphoma Kinase Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance Study
Subject Area:
Oncology
Yoshihiro Noguchi; Hiroki Asano; Rikuto Masuda; Yuta Teshigawara; Makiko Go; Michio Kimura; Eiseki Usami; Tomoaki Yoshimura
Oncology (2024) 102 (11): 996–1003.
https://doi.org/10.1159/000539426
Letter to the Editor
Zinc Supplementation in Head and Neck Cancer: Prevention of Chemo-Radio-Induced Complications and an Opportunity for Treatment
Subject Area:
Oncology
Oncology (2024) 102 (11): 1004–1007.
https://doi.org/10.1159/000540248